Australia and Oceania: Vaccine Market 2024

Vaccine Market Size in Australia and Oceania

The vaccine market in Australia and Oceania dropped markedly to $X in 2022, which is down by X% against the previous year. Over the period under review, consumption, however, enjoyed a resilient expansion. As a result, consumption attained the peak level of $X, and then fell remarkably in the following year.

Vaccine Production in Australia and Oceania

In value terms, vaccine production shrank to $X in 2022 estimated in export price. Overall, production, however, posted a strong expansion. The pace of growth appeared the most rapid in 2018 with an increase of X% against the previous year. Over the period under review, production attained the maximum level at $X in 2019; however, from 2020 to 2022, production stood at a somewhat lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Vaccine Exports

Exports in Australia and Oceania

In 2022, the amount of vaccines for human medicine exported in Australia and Oceania contracted to X tons, shrinking by X% on the previous year's figure. Overall, exports continue to indicate a abrupt decline. The growth pace was the most rapid in 2020 when exports increased by X% against the previous year. Over the period under review, the exports hit record highs at X tons in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

In value terms, vaccine exports dropped rapidly to $X in 2022. In general, exports continue to indicate a abrupt descent. The most prominent rate of growth was recorded in 2021 with an increase of X%. The level of export peaked at $X in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports by Country

Australia prevails in exports structure, recording X tons, which was approx. X% of total exports in 2022. It was distantly followed by New Zealand (X tons), comprising a X% share of total exports.

From 2012 to 2022, average annual rates of growth with regard to vaccine exports from Australia stood at X%. At the same time, New Zealand (X%) displayed positive paces of growth. Moreover, New Zealand emerged as the fastest-growing exporter exported in Australia and Oceania, with a CAGR of X% from 2012-2022. New Zealand (X p.p.) significantly strengthened its position in terms of the total exports, while Australia saw its share reduced by X% from 2012 to 2022, respectively.

In value terms, Australia ($X) remains the largest vaccine supplier in Australia and Oceania, comprising X% of total exports. The second position in the ranking was held by New Zealand ($X), with a X% share of total exports.

In Australia, vaccine exports shrank by an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in Australia and Oceania amounted to $X per kg, shrinking by X% against the previous year. Over the period under review, the export price, however, enjoyed a tangible expansion. The most prominent rate of growth was recorded in 2021 when the export price increased by X%. Over the period under review, the export prices hit record highs at $X per kg in 2019; however, from 2020 to 2022, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Australia ($X per kg), while New Zealand amounted to $X per kg.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by New Zealand (X%).

Vaccine Imports

Imports in Australia and Oceania

In 2022, imports of vaccines for human medicine in Australia and Oceania declined notably to X tons, waning by X% on the previous year. In general, imports, however, continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons, and then declined rapidly in the following year.

In value terms, vaccine imports shrank dramatically to $X in 2022. Over the period under review, imports, however, posted a strong increase. The pace of growth appeared the most rapid in 2021 when imports increased by X% against the previous year. As a result, imports reached the peak of $X, and then dropped rapidly in the following year.

Imports by Country

Australia was the largest importing country with an import of around X tons, which accounted for X% of total imports. It was distantly followed by New Zealand (X tons), generating an X% share of total imports. The following importers - Papua New Guinea (X tons) and New Caledonia (X tons) - together made up X% of total imports.

Australia experienced a relatively flat trend pattern with regard to volume of imports of vaccines for human medicine. At the same time, New Caledonia (X%), Papua New Guinea (X%) and New Zealand (X%) displayed positive paces of growth. Moreover, New Caledonia emerged as the fastest-growing importer imported in Australia and Oceania, with a CAGR of X% from 2012-2022. While the share of New Zealand (X p.p.) and Papua New Guinea (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Australia (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Australia ($X) constitutes the largest market for imported vaccines for human medicine in Australia and Oceania, comprising X% of total imports. The second position in the ranking was held by New Zealand ($X), with a X% share of total imports. It was followed by Papua New Guinea, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in Australia amounted to X%. In the other countries, the average annual rates were as follows: New Zealand (X% per year) and Papua New Guinea (X% per year).

Import Prices by Country

The import price in Australia and Oceania stood at $X,461 per ton in 2022, approximately reflecting the previous year. Over the period under review, the import price, however, enjoyed prominent growth. The growth pace was the most rapid in 2021 an increase of X% against the previous year. As a result, import price reached the peak level of $X,571 per ton, and then contracted in the following year.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was New Zealand ($X,989 per ton), while Papua New Guinea ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by New Zealand (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :